$ALLR Allarity Therapeutics, Inc. Presents Novel
Post# of 163
(Total Views: 37)
Posted On: 04/30/2025 7:25:54 AM
$ALLR Allarity Therapeutics, Inc. Presents Novel Drug Response Predictor--DRP®?-- for Daratumumab in Multiple Myeloma at AACR2025
Allarity Therapeutics, Inc. announced the presentation of a poster containing data on a new DRP for the monoclonal antibody drug daratumumab. The poster is to be presented during a session at the 2025 American Association for Cancer Research (AACR) Annual Meeting, taking place April 25-30, 2025, in Chicago, IL. This novel predictor is designed to identify multiple myeloma patients most likely to benefit from Daratumumab.
https://marketscreener.com/quote/stock/ALLARI...-49736718/
(0)
(0)Scroll down for more posts ▼